GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 15 filers reported holding GAIN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $385 | -99.9% | 123,000 | -18.0% | 0.61% | -3.0% |
| Q3 2022 | $489,000 | -15.1% | 150,000 | -6.2% | 0.63% | -8.1% |
| Q2 2022 | $576,000 | -41.2% | 160,000 | -33.3% | 0.68% | -55.9% |
| Q1 2022 | $979,000 | +21.3% | 240,000 | +58.8% | 1.54% | +48.7% |
| Q4 2021 | $807,000 | +12.7% | 151,132 | +57.0% | 1.04% | +7.7% |
| Q3 2021 | $716,000 | +136.3% | 96,232 | +217.7% | 0.96% | +131.4% |
| Q2 2021 | $303,000 | – | 30,293 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 150,000 | $489,000 | 0.63% |
| CM Management, LLC | 125,000 | $408,000 | 0.46% |
| Greenlight Capital | 546,560 | $1,781,000 | 0.13% |
| Wealth Alliance Advisory Group, LLC | 25,000 | $82,000 | 0.04% |
| Cannell Capital | 12,371 | $40,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $189,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 40,000 | $130,000 | 0.00% |
| HOEY INVESTMENTS, INC | 500 | $2,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 87,967 | $286,000 | 0.00% |